Michael Babich

Oppenheimer said in a note on Wednesday Insys Therapeutics Inc (NASDAQ: INSY) maintains its potential long-term upside. However, the firm said it prefers to be on the sidelines for now. DoJ Investigation Resolution Awaited Analyst Derek Archila said he continues to rate Insys at Perform, as...

Shares of Insys Therapeutics Inc (NASDAQ: INSY) traded down about 17 percent on Thursday afternoon after several former executives and managers were arrested “on charges that they led a nationwide conspiracy to bribe medical practitioners to unnecessarily prescribe a fentanyl-based pain...